Sevilay Altıntaş

2.1k total citations
42 papers, 749 citations indexed

About

Sevilay Altıntaş is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sevilay Altıntaş has authored 42 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sevilay Altıntaş's work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (7 papers). Sevilay Altıntaş is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (7 papers). Sevilay Altıntaş collaborates with scholars based in Belgium, France and United States. Sevilay Altıntaş's co-authors include Wiebren Tjalma, Manon Huizing, A. Vandebroek, Laurent Bastit, Peter A. van Dam, Tamás Sütö, Tamás Pintér, Zwi Berneman, Jan B. Vermorken and Marc Peeters and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sevilay Altıntaş

39 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevilay Altıntaş Belgium 15 291 188 164 137 122 42 749
Suriya Jeyapalan United States 13 262 0.9× 65 0.3× 287 1.8× 372 2.7× 92 0.8× 33 926
Robin E. Norris United States 14 211 0.7× 75 0.4× 121 0.7× 60 0.4× 325 2.7× 46 694
Karim Malek United States 15 313 1.1× 41 0.2× 91 0.6× 107 0.8× 275 2.3× 30 716
Hiroki Yoshida Japan 15 272 0.9× 206 1.1× 394 2.4× 158 1.2× 304 2.5× 55 1.3k
Robert D. Legare United States 14 449 1.5× 230 1.2× 75 0.5× 31 0.2× 150 1.2× 35 822
Ciara L. Freeman United States 15 451 1.5× 42 0.2× 237 1.4× 173 1.3× 279 2.3× 87 934
Julie Chang United States 14 383 1.3× 68 0.4× 72 0.4× 261 1.9× 194 1.6× 44 806
Daniel Buergy Germany 13 289 1.0× 143 0.8× 39 0.2× 48 0.4× 157 1.3× 29 674
Robert Königsberg Austria 16 676 2.3× 357 1.9× 365 2.2× 126 0.9× 536 4.4× 31 1.5k
Stephen S. Roberts United States 20 382 1.3× 303 1.6× 54 0.3× 126 0.9× 508 4.2× 73 1.3k

Countries citing papers authored by Sevilay Altıntaş

Since Specialization
Citations

This map shows the geographic impact of Sevilay Altıntaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevilay Altıntaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevilay Altıntaş more than expected).

Fields of papers citing papers by Sevilay Altıntaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevilay Altıntaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevilay Altıntaş. The network helps show where Sevilay Altıntaş may publish in the future.

Co-authorship network of co-authors of Sevilay Altıntaş

This figure shows the co-authorship network connecting the top 25 collaborators of Sevilay Altıntaş. A scholar is included among the top collaborators of Sevilay Altıntaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevilay Altıntaş. Sevilay Altıntaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindemann, Kristina, Dominique Berton-Rigaud, Jalid Sehouli, et al.. (2025). NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. Gynecologic Oncology. 199. 79–87.
2.
Öner, Gizem, Hans Stoop, Gayathri R. Devi, et al.. (2025). Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer. Breast Cancer Targets and Therapy. Volume 17. 211–224.
3.
Öner, Gizem, Glenn Broeckx, Christophe Van Berckelaer, et al.. (2023). The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy. Cancer Medicine. 12(17). 17901–17913. 7 indexed citations
4.
Vergote, Ignace, Hannelore Denys, Sevilay Altıntaş, et al.. (2022). Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion. Facts Views and Vision in ObGyn. 14(2). 111–120. 2 indexed citations
5.
6.
Öner, Gizem, Sevilay Altıntaş, Zafer Cantürk, et al.. (2020). The immunologic aspects in hormone receptor positive breast cancer. Cancer Treatment and Research Communications. 25. 100207–100207. 11 indexed citations
7.
Öner, Gizem, Sevilay Altıntaş, Zafer Cantürk, et al.. (2019). Triple‐negative breast cancer—Role of immunology: A systemic review. The Breast Journal. 26(5). 995–999. 41 indexed citations
8.
9.
Haan, J. de, Christianne Lok, Christianne J.M. de Groot, et al.. (2017). Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma. Melanoma Research. 27(3). 218–223. 10 indexed citations
10.
Berckelaer, Christophe Van, Manon Huizing, Mireille Van Goethem, et al.. (2016). Preoperative ultrasound staging of the axilla make’s peroperative examination of the sentinel node redundant in breast cancer: saving tissue, time and money. European Journal of Obstetrics & Gynecology and Reproductive Biology. 206. 164–171. 8 indexed citations
11.
Dam, Peter A. van, et al.. (2015). Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?. European Journal of Surgical Oncology. 42(3). 333–342. 14 indexed citations
12.
Papadimitriou, Konstantinos, et al.. (2015). Ductal carcinoma in situ: a disease entity that merits more recognition.. PubMed. 70(4). 231–9. 2 indexed citations
13.
Papadimitriou, Konstantinos, Christian Rolfo, Jan Van den Brande, et al.. (2015). Incorporating Anti-VEGF Pathway Therapy as a Continuum of Care in Metastatic Colorectal Cancer. Current Treatment Options in Oncology. 16(4). 18–18. 9 indexed citations
14.
Aftimos, Philippe, Véronique Dièras, Sevilay Altıntaş, et al.. (2014). Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors. Annals of Oncology. 25. i25–i25. 3 indexed citations
15.
Brandsma, Dieta, Bojana Milojkovic Kerklaan, Véronique Dièras, et al.. (2014). Phase 1/2A Study of Glutathione Pegylated Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (Bm) from Solid Tumors or Recurrent High Grade Gliomas (Hgg). Annals of Oncology. 25. iv157–iv157. 23 indexed citations
16.
Altıntaş, Sevilay, Virginie Durbecq, Kathleen Lambein, et al.. (2011). Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS). The Breast Journal. 17(4). 343–351. 15 indexed citations
17.
Durbecq, Virginie, Sevilay Altıntaş, Ghizlane Rouas, et al.. (2010). Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS). PLoS ONE. 5(8). e12100–e12100. 44 indexed citations
18.
Durbecq, Virginie, Benjamin Haibe‐Kains, Sevilay Altıntaş, et al.. (2009). Decreased CD10 Expression Is Associated with a Higher Risk of Relapse in Ductal Carcinoma In Situ (DCIS).. Cancer Research. 69(24_Supplement). 2112–2112. 1 indexed citations
19.
Specenier, Pol, Joost Weyler, Carl Van Laer, et al.. (2009). A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 9(1). 273–273. 8 indexed citations
20.
Droogenbroeck, Jan Van, et al.. (2001). Intravascular large B-cell lymphoma or intravascular lymphomatosis: report of a case diagnosed by testicle biopsy. Annals of Hematology. 80(5). 316–318. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suriya Jeyapalan Breakdown of academic impact, for papers by Robin E. Norris Breakdown of academic impact, for papers by Karim Malek Breakdown of academic impact, for papers by Hiroki Yoshida Breakdown of academic impact, for papers by Robert D. Legare Breakdown of academic impact, for papers by Ciara L. Freeman Breakdown of academic impact, for papers by Julie Chang Breakdown of academic impact, for papers by Daniel Buergy Breakdown of academic impact, for papers by Robert Königsberg Breakdown of academic impact, for papers by Stephen S. Roberts
Rankless by CCL
2026